Cargando…

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes

BACKGROUND: Frailty and multimorbidity are common in type 2 diabetes (T2D), including people <65 years. Guidelines recommend adjustment of treatment targets in people with frailty or multimorbidity. It is unclear how recommendations to adjust treatment targets in people with frailty or multimorbi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanlon, Peter, Jani, Bhautesh D., Butterly, Elaine, Nicholl, Barbara, Lewsey, Jim, McAllister, David A., Mair, Frances S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053176/ https://www.ncbi.nlm.nih.gov/pubmed/35602215 http://dx.doi.org/10.1038/s43856-021-00029-9

Ejemplares similares

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
por: Hanlon, Peter, et al.
Publicado: (2022)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2018)

Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort
por: Corcoran, Neave ME, et al.
Publicado: (2022)

Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
por: Hanlon, Peter, et al.
Publicado: (2020)

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2019)

Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis
por: Hanlon, Peter, et al.
Publicado: (2020)

Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
por: Hanlon, Peter, et al.
Publicado: (2020)

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2018)

Frailty in people with rheumatoid arthritis: a systematic review of observational studies
por: Hanlon, Peter, et al.
Publicado: (2022)

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
por: Hanlon, Peter, et al.
Publicado: (2018)

Risk Factors and Mortality Associated with Multimorbidity in People with Stroke or Transient Ischaemic Attack: A Study of 8,751 UK Biobank Participants
por: Gallacher, Katie I., et al.
Publicado: (2018)

Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank
por: McQueenie, Ross, et al.
Publicado: (2021)

Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2020)

Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants
por: McQueenie, Ross, et al.
Publicado: (2020)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort
por: Sullivan, Michael K, et al.
Publicado: (2021)

Associations between long-term conditions and upper gastrointestinal cancer incidence: A prospective population-based cohort of UK Biobank participants
por: Marley, Jennifer, et al.
Publicado: (2021)

Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition
por: Wightman, Heather, et al.
Publicado: (2023)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD
por: Hanlon, Peter, et al.
Publicado: (2023)

Examining the relationship between rheumatoid arthritis, multimorbidity and adverse health-related outcomes: A systematic review protocol
por: Canning, Jordan, et al.
Publicado: (2020)

Prevalence, measurement, and implications of frailty in stroke survivors: An analysis of three global aging cohorts
por: Hanlon, Peter, et al.
Publicado: (2023)

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
por: Sullivan, Michael K., et al.
Publicado: (2021)

Social connection and mortality in UK Biobank: a prospective cohort analysis
por: Foster, Hamish M. E., et al.
Publicado: (2023)

Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank
por: Petermann-Rocha, Fanny, et al.
Publicado: (2020)

Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2021)

Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study
por: McLoone, Philip, et al.
Publicado: (2023)

Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts
por: Chiang, Jason I., et al.
Publicado: (2020)

The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
por: Sullivan, Michael K., et al.
Publicado: (2022)

Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study
por: Hastie, Claire E., et al.
Publicado: (2023)

COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants
por: Woolford, Stephen, et al.
Publicado: (2020)

Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
por: Niedzwiedz, Claire L., et al.
Publicado: (2020)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
por: Chiang, Jason I, et al.
Publicado: (2020)

Family history of diabetes and risk of SARS‐COV‐2 in UK Biobank: A prospective cohort study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2021)

COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants
por: Woolford, S. J., et al.
Publicado: (2020)

Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
por: Hanlon, Peter, et al.
Publicado: (2023)

Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review
por: Chiang, Jason I., et al.
Publicado: (2018)

Impact of multimorbidity count on all-cause mortality and glycaemic outcomes in people with type 2 diabetes: a systematic review protocol
por: Chiang, Jason I, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ab8cldrtilssquokbq59n7nolg